A comparison of magnesium sulphate and sildenafil in the treatment of the newborns with persistent pulmonary hypertension: A randomized controlled trial

Journal of Tropical Pediatrics

Volumn 57, Issue 4, 2011, Pages 245-250

  Uslu, Sinan ^a,b   Kumtepe, Soner ^b   Bulbul, Ali ^a   Comert, Serdar ^a   Bolat, Fatih ^a   Nuhoglu, Asiye ^a  

^a Sisli Children Hospital   (Turkey)

^b Diyarbakir Children Hospital   (Turkey)

Author keywords

Magnesium sulfate; Newborn; Pulmonary hypertension; Sildenafil

Indexed keywords

DOPAMINE; INOTROPIC AGENT; MAGNESIUM SULFATE; SILDENAFIL;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LOADING DRUG DOSE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DISEASE; OXYGENATION; PERSISTENT PULMONARY HYPERTENSION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MAGNESIUM SULFATE; MALE; OXYGEN; PERSISTENT FETAL CIRCULATION SYNDROME; PIPERAZINES; PROSPECTIVE STUDIES; PURINES; RESPIRATION, ARTIFICIAL; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 79961077698     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq091     Document Type: Article

References (25)

1. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: A report of the American College of Cardiology Foundation Task Force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-619.
2. Kohelet D, Perlman M, Kirpalani H, et al. High-frequency oscillation in the rescue of infants with persistent pulmonary hypertension. Crit Care Med 1988;16:510-16.
3. Wu TJ, Teng RJ, Tsou KI. Persistent pulmonary hypertension of the newborn treated with magnesium sulfate in premature neonates. Pediatrics 1995;96:472-4.
4. Baquero H, Soliz A, Nelro F, et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomised blinded study. Pediatrics 2006;117:1077-83.
5. Ng C, Franklin O, Vaidya M, et al. Adenosine infusion for the management of persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 2004;5:10-13.
6. Nakwan N, Choksuchat D, Saksawad R, et al. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan. Acta Paediatr 2009;98:1683-5.
7. Golzand E, Bar-Oz B, Arad I. Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide. Isr Med Assoc J 2005;7:408-9.
8. Boden G, Bennett C. The management of persistent pulmonary hypertension of the newborn. Curr Paed 2004;14:290-7.
9. Roberts JD, Polaner DM, Lang P. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-19.
10. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989;84:957-63.
11. Juliana AE, Abbad FCB. Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: succesful treatment with sildenafil. Eur J Pediatr 2005;164:626-9.
12. Abu-Osba YK, Galal O, Manasra K, et al. Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 1992;67:31-5.
13. Dehdashtian M, Tebatebae K. Magnesium sulphate as a safe treatment for persistent pulmonary hypertension of newborn resistant to mechanical hyperventilation. Pak J Med Sci 2007;23:693-7.
14. Seri I, Evans J. Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr 2001;13:116-23.
15. Greenough A, Khetriwal B. Pulmonary hypertension in the newborn. Paediatric Respir Rew 2005;6:111-16.
16. Ho JJ, Rasa G. Magnesium sulfate for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev 2007;18:CD005588.
17. Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev 2007;18:CD005494.
18. Abu-Osba YK, Rhydderch D, Balasundaram S, et al. Reduction of hypoxia-induced pulmonary hypertension (HIPH) by MgSO4 in sheep. Pediatr Res 1990;27:351A.
19. Tolsa JF, Cotting J, Sekarski N, et al. Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child 1995;72:184-7.
20. Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 2002;165:1098-102.
21. Chandran S, Haqueb ME, Wickramasinghe HT, et al. Use of magnesium sulphate in severe persistent pulmonary hypertension of the newborn. J Trop Pediatr 2004;50:219-23.
22. Steinhorn RH, Kinsella JP, Pierce C, et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 2009;155:841-7.
23. Martell M, Blasina F, Silvera F, et al. Intratracheal sildenafil in the newborn with pulmonary hypertension. Pediatrics 2007;119:215-16.
24. Daffa SH, Milaat WA. Role of magnesium sulphate in treatment of severe persistent pulmonary hypertension of the neoborn. Saudi Med J 2002;23:1266-9.
25. de Rosalmeida MC, Saraiva LD, da Graca JR, et al. Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Dig Dis Sci 2003;48:2064-8.